Akari Therapeutics, Plc (AKTX)

Akari Therapeutics, Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.6	3.85	13.25	9.36	14.06
Cash & Short-Term Investments	2.6	3.85	13.25	9.36	14.06
Cash Growth	-32.41%	-70.98%	41.54%	-33.40%	145.23%
Prepaid Expenses	0.09	0.3	0.47	2.17	0.29
Restricted Cash	0.06	-	-	-	-
Other Current Assets	0.2	0.2	0.1	0.09	0.23
Total Current Assets	2.95	4.34	13.82	11.63	14.58
Goodwill	8.43	-	-	-	-
Other Intangible Assets	39.18	0.01	0.02	0.02	0.03
Total Assets	50.56	4.36	13.83	11.65	14.6
Accounts Payable	12.41	1.67	0.95	1.79	3.38
Accrued Expenses	3.14	1.57	3.15	3.18	1.84
Short-Term Debt	3.26	-	-	-	-
Other Current Liabilities	1.11	1.35	7.95	1.12	-
Total Current Liabilities	19.91	4.58	12.04	6.09	5.22
Long-Term Deferred Tax Liabilities	8.04	-	-	-	-
Other Long-Term Liabilities	0.38	-	-	-	-
Total Liabilities	28.33	4.58	12.04	6.09	5.22
Common Stock	5.32	1.32	0.75	0.48	0.38
Additional Paid-In Capital	212.71	174.75	167.08	153.13	139.73
Retained Earnings	-247.25	-227.46	-217.45	-199.71	-182.28
Comprehensive Income & Other	51.46	51.15	51.42	51.65	51.55
Shareholders' Equity	22.23	-0.23	1.79	5.55	9.38
Total Liabilities & Equity	50.56	4.36	13.83	11.65	14.6
Total Debt	3.26	-	-	-	-
Net Cash (Debt)	-0.66	3.85	13.25	9.36	14.06
Net Cash Growth	-	-70.98%	41.54%	-33.40%	145.23%
Net Cash Per Share	-0.06	0.79	4.24	4.36	8.90
Filing Date Shares Outstanding	28.88	7.92	5.06	2.97	1.92
Total Common Shares Outstanding	26.59	6.62	3.72	2.38	1.92
Working Capital	-16.96	-0.24	1.77	5.53	9.36
Book Value Per Share	0.84	-0.03	0.48	2.33	4.88
Tangible Book Value	-25.38	-0.24	1.77	5.53	9.36
Tangible Book Value Per Share	-0.95	-0.04	0.48	2.32	4.86
Machinery	-	-	-	0.16	0.16

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q